Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall digital discussions reflect a balanced view, with posters showing strong agreement towards the importance of the guidelines, especially by emphasizing statins' role and risk assessment tools like CAC scores. The tone often highlights practical applications, such as integrating risk factors like obesity and diabetes, which indicates a deep engagement with both the recommendations and their clinical implications. The interest level is high, given references to specific studies and the mention of ongoing debates about testing and treatment strategies, illustrating the perceived importance of the publication's content.
Most discussions recognize the authoritative nature of the 2018 guidelines, with some posts emphasizing the continued importance of statins and risk assessment strategies.
Posts demonstrate high curiosity by referencing specific tools like the CAC score and discussing nuances such as modifications in cholesterol management, indicating strong relevance.
Many discussions delve into procedural details, like risk stratification and the role of LDL-C, and cite research studies, showing deep involvement with the guidelines.
While some posts suggest these guidelines influence clinical practice, the overall tone suggests recognition of their significance but less certainty about immediate transformative impact.
La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo: -IMC ≥30 -Glucosa en ayunas ≥100 mg/dl -Síndrome metabólico -Hemoglobina glucosilada ≥6% J Am Coll Cardiol 2018;doi: https://t.co/I3QQlsihnP.
Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddleEast 2021 Hybrid education sessions are underway this morning! Her top takeaway slide
Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-society Guideline on Blood Cholesterol Management. #Cardiology #CholesterolGuidelines #CholesterolEducationMonth https://t.co/JecJi1Hbzf https://t.co/Mp59V1HU65
#CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) para el manejo del colesterol. Leer + aquí >> https://t.co/4wCOsaLzVF #Cardiología #SVC Por el Dr. Juan Humphreys https://t.co/qsVdkzEa4g
@kevinnbass @hjluks Read how they are put together https://t.co/C4JnStcaHk
This is for whoever named the cholesterol guidelines:2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines https://t.co/eZ0L9yDuwL
This video reviews 2018 guidelines on managing blood cholesterol to prevent cardiovascular disease, covering assessment, treatment options, and risk reduction strategies. Learn evidence-based approaches for effective…
This video examines the scientific evidence behind Berberine's claims for blood sugar control, cholesterol reduction, weight loss, cancer prevention, and anti-aging, comparing it to medications like metformin and…
The CardioNerds discuss lipid management, emphasizing preventing ASCVD through lifestyle changes and medications, with personalized treatment based on individual risk factors. Topics include LDL reduction, statin use…
5) In the setting of primary prevention, beyond recommending #lifestyle changes, it is important to assess the risk of ischemic events and base #cholesterol-lowering therapy on that. If patients are high enough risk, statin therapy is indicated. See
RT @cardiomet_CE: 7) The coronary artery calcium (#CAC) score can be used to help decide whether to use statins in intermediate risk adults…
7) The coronary artery calcium (#CAC) score can be used to help decide whether to use statins in intermediate risk adults aged 40-75 years. See
6) In the setting of primary prevention, beyond recommending #lifestyle changes, it is important to assess the risk of ischemic events and base #cholesterol lowering therapy on that. If patients are high enough risk, statin therapy is indicated. See
10/ References: [1] Grundy SM et al. JACC. 2019;73(24):e285-e350. doi:10.1016/j.jacc.2018.11.003 [2] Oyama K et al. JACC. 2021;78(15):1499-1507 [3] Lloyd-Jones DM et al. JACC. 2022;80(14):1366-1418 [4] Zhan S et al. Cochrane Rev. 2018;11:CD012502
RT @cardiomet_CE: 10b) Given that ⬇️ing #LDL-C with proven agents ⬇️ #CVD risk, pts at high CVD risk w/ #obesity & #hypercholesterolemia ma…
10b) Given that ⬇️ing #LDL-C with proven agents ⬇️ #CVD risk, pts at high CVD risk w/ #obesity & #hypercholesterolemia may benefit from a dual approach of interventions that promote both ⬇️in LDL-C & weight ⬇️. See
@FrogHarmless @LowCarbEyeDoc @realDaveFeldman A bit old (2018) but you get the point. "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol" https://t.co/Us16k7gnO3
Thank you for sticking around till the end. There are books written on HLD but I hope this brief tweetorial was helpful to new/ future PGY-1s. To learn about more things Cardiology, check us out @CardiologyUniv . to learn more: https://t.co/2XZEZCdP5g
RT @nationallipid: Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-societ…
RT @nationallipid: Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-societ…
RT @nationallipid: Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-societ…
Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-society Guideline on Blood Cholesterol Management. #Cardiology #CholesterolGuidelines #CholesterolEducationMonth https://t.co/JecJi1Hbzf https://t.co/BApsO1jlkh
Statins continue to be the foundational treatment for reducing cholesterol as confirmed by the 2018 AHA/ACC/multi-society Guideline on Blood Cholesterol Management. #Cardiology #CholesterolGuidelines #CholesterolEducationMonth https://t.co/JecJi1Hbzf https://t.co/Mp59V1HU65
RT @hecmedint: @Dr_Vica @Ramon_Angel_MD @sandydamus https://t.co/0tzFjT8dvM
@Dr_Vica @Ramon_Angel_MD @sandydamus https://t.co/0tzFjT8dvM
@Ramon_Angel_MD @Dr_Vica @sandydamus https://t.co/0tzFjT8dvM
@usual_unknown @Kingfidrally1 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: ✨ https://t.co/QY60d5kL2K
RT @DrNadolsky: @kevinnbass @hjluks Read how they are put together https://t.co/C4JnStcaHk
@kevinnbass @hjluks Read how they are put together https://t.co/C4JnStcaHk
ステロイドとか飲んでるし 脂質異常症の学び直しと軽い気持ちで論文読み始めたら 半日経過
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
RT @ACCinTouch: Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddle…
Immediate Past ACC President Dr. @athenapoppas is presenting on novel risk enhancers for #CV disease in women as #ACCMiddleEast 2021 Hybrid education sessions are underway this morning! Her top takeaway slide
Dr. Boz Reviews Guidelines on Cholesterol, Statins, & Risk for Coronary Artery Disease - YouTube https://t.co/UjFzOfsxH4
Reference: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Web Supplement
The #2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA #guidelines on the management of blood #cholesterol in #diabetes. https://t.co/cOZ2bRyDjc
Most healthy adults not on statins don't have to take a fasted blood test for accuracy. https://t.co/xhCTwsPSjy
@Karageorgos15 2018 multisoc recs label LDL-C ≥190 mg/dL as severe hypercholesterolemia. See pgs e300-1 of below link. This reflects the idea that those w highest baseline LDL-C (∴ most absolute ⬇️LDL-C w lipid-lowering tx) will in general achieve the greatest benefit. https://t.co/OhpGdXDurx
@zadigbarcelo @docisa33 Tout à fait, des recommandations avec un niveau de preuve particulièrement faible et entachées de conflits d'intérêt. Mieux vaut se tourner vers les recommandations américaines de l'AHA/ACC qui sont plus scientifiques: https://t.co/fZWZr7OR9B
The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes https://t.co/nPdY3FSlZy
The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes https://t.co/37vQexGIQB
The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes https://t.co/6BFgmGF8L6
This is for whoever named the cholesterol guidelines:2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines https://t.co/eZ0L9yDuwL
There are a lot of ridiculous acronym combinations in medicine, but I think the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol really takes the cake. https://t.co/vdCFGPCryG
Spotlight From the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol https://t.co/EdV758UKsP https://t.co/kKtnPa3UBO
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline Management of Blood Cholesterol: Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines - ScienceDirect https://t.co/MK4v9ENldt
RT @tripdatabase: New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of B…
New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of Blood Cholesterol: Report of American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines https://t.co/QrvDwPa4pO
RT @tripdatabase: New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of B…
#EBM EvidenceAlerts | 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. https://t.co/np8HQvxUpC
RT @tripdatabase: New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of B…
RT @tripdatabase: New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of B…
New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of Blood Cholesterol: Report of American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines https://t.co/QrvDwPa4pO
RT @tripdatabase: New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of B…
RT @tripdatabase: New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of B…
New2Trip: Systematic Review for 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on Management of Blood Cholesterol: Report of American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines https://t.co/QrvDwPa4pO
Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol. https://t.co/pzgbMQE1sM
@Joe_Vassalotti 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol #Nephpearls
EvidenceAlerts | 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. https://t.co/CGdKiJVOyE
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines - https://t.co/61Qo3j2lFT https://t.co/qtP4IS3ssg
RT @MazenSalama: Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Bloo…
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines - https://t.co/rT39E1F4yy
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines - https://t.co/SbpA524R6g https://t.co/yzXqojBsGf
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol | Circulation https://t.co/FkcquPX9jv
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline... https://t.co/TOl0fe5ULf
RT @3Ccardio: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) para el…
#CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) para el manejo del colesterol. Leer + aquí >> https://t.co/4wCOsaLzVF #Cardiología #SVC Por el Dr. Juan Humphreys https://t.co/tueODl9Tu9
RT @3Ccardio: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) para el…
#CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) para el manejo del colesterol. Leer + aquí >> https://t.co/vUmpHOR5yu #Cardiología #3C Por el Dr. Juan Humphreys https://t.co/S9NLJBK8OS
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) p…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) p…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) p…
#CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) para el manejo del colesterol. Leer + aquí >> https://t.co/4wCOsaLzVF #Cardiología #SVC Por el Dr. Juan Humphreys https://t.co/MIyWx0yhvx
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline... https://t.co/y6N6dTj1Rb
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
RT @AmbrizMau: La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo:…
La diabetes mellitus asociada a terapia con estatinas se puede presentar en pacientes con los siguientes factores de riesgo: -IMC ≥30 -Glucosa en ayunas ≥100 mg/dl -Síndrome metabólico -Hemoglobina glucosilada ≥6% J Am Coll Cardiol 2018;doi: https://t.co/I3QQlsihnP.
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol | Circulation https://t.co/RUzWN3RpXk
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the A... - PubMed - NCBI https://t.co/cVIBFS2Itw
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
RT @hhamasaki78: Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Bloo…
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol | Circulation https://t.co/6y6HLf9zrq
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
RT @CardiologiaSVC: #CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2)…
#CardioDato Las nuevas Guías 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA (1-2) para el manejo del colesterol. Leer + aquí >> https://t.co/4wCOsaLzVF #Cardiología #SVC Por el Dr. Juan Humphreys https://t.co/qsVdkzEa4g
MA
AC
NA
SC
DN
K
CM
VC
MⲂ
DG
BE
IS
BJ
GP
CM
B
H
م
LG
E
دس
CM
JJ
CP
M
DK
TM
DA
M
HC
BM
CS
TS
S
TD
MG
E
ER
KS
CT
EL
TS
D
EJ
H
DV
RV
RC
CC
MS
D
YM
SV
M
JH
JS
DS
R
キ
JM
RM
JG
SF
HH
LR
YM
FR